Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Frontiers in Bioscience (Landmark Edition)
|
September 30, 2021
Pregnancy, a unique case of heterochronic parabiosis and peripartum cardiomyopathy
Pascal J Goldschmidt-Clermont, Corinne Hubinont, Alexander J P Goldschmidt, et al.
Journal of Cardiovascular Translational Research
|
October 31, 2014
Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy
Muzammil Mushtaq, Darcy L DiFede, Samuel Golpanian, et al.
The Journal of Sexual Medicine
|
February 16, 2020
The Effect of Transendocardial Stem Cell Injection on Erectile Function in Men With Cardiomyopathy: Results From the TRIDENT, POSEIDON, and TAC-HFT Trials
Jesse Ory, Russell G Saltzman, Ruben Blachman-Braun, et al.
Journal of the American College of Cardiology
|
January 17, 2015
Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients
Samuel Golpanian, Jill El-Khorazaty, Adam Mendizabal, et al.
Stem Cells and Development
|
January 17, 2018
Simulated Microgravity Impairs Cardiac Autonomic Neurogenesis from Neural Crest Cells
Konstantinos E Hatzistergos, Zhijie Jiang, Krystalenia Valasaki, et al.
Journal of Neurotrauma
|
May 24, 2018
Clinical and Neurophysiological Changes after Targeted Intrathecal Injections of Bone Marrow Stem Cells in a C3 Tetraplegic Subject
Andrea J Santamaría, Francisco D Benavides, Darcy L DiFede, et al.
Ebiomedicine
|
July 3, 2015
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
Courtney Premer, Arnon Blum, Michael A Bellio, et al.
Ebiomedicine
|
October 26, 2019
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
Angela C Rieger, Robert J Myerburg, Victoria Florea, et al.
Stem Cells Translational Medicine
|
December 20, 2015
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
Samuel Golpanian, Ivonne H Schulman, Ray F Ebert, et al.
Oncotarget
|
March 3, 2016
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
Samuel Golpanian, Darcy L DiFede, Marietsy V Pujol, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Frontiers in Bioscience (Landmark Edition)
|
September 30, 2021
Pregnancy, a unique case of heterochronic parabiosis and peripartum cardiomyopathy
Pascal J Goldschmidt-Clermont, Corinne Hubinont, Alexander J P Goldschmidt, et al.
Journal of Cardiovascular Translational Research
|
October 31, 2014
Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy
Muzammil Mushtaq, Darcy L DiFede, Samuel Golpanian, et al.
The Journal of Sexual Medicine
|
February 16, 2020
The Effect of Transendocardial Stem Cell Injection on Erectile Function in Men With Cardiomyopathy: Results From the TRIDENT, POSEIDON, and TAC-HFT Trials
Jesse Ory, Russell G Saltzman, Ruben Blachman-Braun, et al.
Journal of the American College of Cardiology
|
January 17, 2015
Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients
Samuel Golpanian, Jill El-Khorazaty, Adam Mendizabal, et al.
Stem Cells and Development
|
January 17, 2018
Simulated Microgravity Impairs Cardiac Autonomic Neurogenesis from Neural Crest Cells
Konstantinos E Hatzistergos, Zhijie Jiang, Krystalenia Valasaki, et al.
Journal of Neurotrauma
|
May 24, 2018
Clinical and Neurophysiological Changes after Targeted Intrathecal Injections of Bone Marrow Stem Cells in a C3 Tetraplegic Subject
Andrea J Santamaría, Francisco D Benavides, Darcy L DiFede, et al.
Ebiomedicine
|
July 3, 2015
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
Courtney Premer, Arnon Blum, Michael A Bellio, et al.
Ebiomedicine
|
October 26, 2019
Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy
Angela C Rieger, Robert J Myerburg, Victoria Florea, et al.
Stem Cells Translational Medicine
|
December 20, 2015
Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease
Samuel Golpanian, Ivonne H Schulman, Ray F Ebert, et al.
Oncotarget
|
March 3, 2016
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
Samuel Golpanian, Darcy L DiFede, Marietsy V Pujol, et al.
Page
of 3